The Leukocyte Protein L1 in Plasma and Synovial Fluid from Patients with Rheumatoid Arthritis and Osteoarthritis

References

• Munthe E, Fagerhol M, Jellum E, Rico P. The leukocyte L1 protein. A new and better marker of disease activity in rheumatoid arthritis. Abstract from XVI Int. Congress of Rheumatol, Sydney. 1985, Abstr 124
   Google Scholar
• Berntzen H B., Munthe E, Fagerhol M K. The major leukocyte protein L1 as an indicator of inflammatory joint disease. Scand J Rheumatol 1988; 76: 251–6, (Suppl.)
   Google Scholar
• Berntzen H B., Munthe E, Fagerhol M K. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol 1989; 16: 1416–20
   PubMed Web of Science ®Google Scholar
• Berntzen H B., Fagerhol M K., Østensen M, Mowinckel P, Høyeraal H M. The Ll protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis. J Rheumatol
   Web of Science ®Google Scholar
• Dale I, Fagerhol M K., Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the Ll antigen. Eur J Biochem 1983; 134: 1–6
   PubMedGoogle Scholar
• Dale I, Brandtzaeg P, Fagerhol M K., Scott H. Distribution of a new myelomonocytic antigen (Ll) in human peripheral blood leukocytes: Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol 1985; 84: 24–34
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P, Dale I, Fagerhol M K. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am J Clin Pathol 1987; 87: 700–7
   PubMed Web of Science ®Google Scholar
• Gabrielsen T-Ø S., Dale I, Brandtzaeg P, et al. Epidermal and dermal distribution of a myelomonocytic antigen (L1) shared by epithelial cells in various inflammatory skin diseases. J Am Acad Dermatol 1986; 15: 173–9
   PubMed Web of Science ®Google Scholar
• Fagerhol M K., Andersson K B., Naess-Andresen C-F, Brandtzaeg P, Dale I. Calprotectin (= The Ll leukocyte protein). Stimulus-response coupling. The role of intracellular calcium, V L. Smith, J R. Dedman. The Telford Press, Caldwell, N J 1990, (in press)
   Google Scholar
• Fagerhol M K., Dale I, Andersson T. A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells. Bull Eur Physiopathol Respir 1980; 16: 273–81, (suppl)
   PubMedGoogle Scholar
• Fagerhol M K., Dale I, Andersson T. Release and quantitation of a leucocyte derived protein (L1). Scand J Haematol 1980; 24: 393–8
   Google Scholar
• Dale I, Fagerhol M K., Frigård M. Quantitation of a highly immunogenic leukocyte antigen (L1) by radioimmunoassay: Methodological evaluation. J Immunol Methods 1983; 65: 245–55
   PubMed Web of Science ®Google Scholar
• Berntzen H B., Fagerhol M K. L1, a major granulocyte protein: antigenic properties of its subunits. Scand J Clin Lab Invest 1988; 48: 647–52
   PubMed Web of Science ®Google Scholar
• Odink K, Cerletti N, Brüggen J, et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987; 330: 80–2
   PubMed Web of Science ®Google Scholar
• Dorin J R., Novak M, Hill R E., et al. A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature 1987; 326: 614–7
   PubMed Web of Science ®Google Scholar
• Wilkinson M M., Busuttil A, Hayward C, Brock D JH, Dorin J R., van Heyningen V. Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. J Cell Sci 1988; 91: 221–30
   PubMed Web of Science ®Google Scholar
• Kelly S E., Jones D B., Fleming S. Calgranulin expression in inflammatory dermatoses. J Pathol 1989; 159: 17–21
   PubMed Web of Science ®Google Scholar
• Andersson K B., Sletten K, Berntzen H B., et al. The leucocyte L1 protein: Identity with the cystic fibrosis antigen and the calcium-binding MRP-8 and MRP-14 macrophage components. Scand J Immunol 1988; 28: 241–5
   PubMed Web of Science ®Google Scholar
• McNamara M P., Wiessner J H., Collins-Lech C, Hahn B L., Sohnle P G. Neutrophil death as a defence mechanism against Candida albicans infections. Lancet 1988; II: 1163–5, 8621
   Google Scholar
• Sohnle P G., Collins-Lech C. An unusual type of host defense mediated by the cytoplasm of neutrophils. Clin Res 1989; 37: 440A
   Google Scholar
• Steinbakk M, Næss-Andresen C-F, Lingaas E, Dale I, Brandtzaeg P, Fagerhol M K. The calcium-binding leucocyte L1 protein is an antimicrobial factor: Calprotectin. Lancet 1990; 336: 763–5
   PubMed Web of Science ®Google Scholar
• Ropes M W., Bennett G A., Cobb S, Jacox R, Jessar R A. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175–6
   PubMedGoogle Scholar
• Emery P, Lopez A F., Burns G F., Vadas M A. Synovial fluid neutrophils of patients with rheumatoid arthritis have membrane antigen changes that reflect activation. Ann Rheum Dis 1988; 47: 34–9
   PubMed Web of Science ®Google Scholar
• Hollingsworth J W., Siegel E R., Creasey W A. Granulocyte survival in synovial exudate of patients with rheumatoid arthritis and other inflammatory joint diseases. Yale J Biol Med 1967; 39: 289–96
   PubMed Web of Science ®Google Scholar
• Adeyemi E O., Hull R G., Chadwick V S., Hughes G RV, Hodgson H JF. Circulating human leucocyte elastase in rheumatoid arthritis. Rheumatol Int 1986; 6: 57–60
   PubMed Web of Science ®Google Scholar
• Feltelius N, Hällgren R. Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment. Ann Rheum Dis 1988; 47: 10–14
   PubMed Web of Science ®Google Scholar
• Ekerot L, Ohlsson K. Immunoreactive granulocyte elastase in rheumatoid synovial fluid and membrane. Scand J Plast Reconstr Surg 1982; 16: 117–22
   PubMed Web of Science ®Google Scholar
• Kushner I, Somerville J A. Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation. Arthritis Rheum 1971; 14: 560–70
   PubMed Web of Science ®Google Scholar
• Swaak A J., van Rooyen A, Nieuwenhuis E, Aarden L A. Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. Scand J Rheumatol 1988; 17: 469–74
   PubMed Web of Science ®Google Scholar
• Guerne P-A, Zuraw B L., Vaughan J H., Carson D A., Lotz M. Synovium as a source of interleukin 6 in vitro. J Clin Invest 1989; 83: 585–92
   PubMed Web of Science ®Google Scholar
• Wallis W J., Simkin P A., Nelp W B. Protein traffic in human synovial effusions. Arthritis Rheum 1987; 30: 57–63
   PubMed Web of Science ®Google Scholar
• Rowe I F., Sheldon J, Riches P G., Keat A CS. Comparative studies of serum and synovial fluid C reactive protein concentrations. Ann Rheum Dis 1987; 46: 721–6
   PubMed Web of Science ®Google Scholar
• Clemmensen I, Donde R, Andersen R B. The primary plasmin inhibitor in rheumatoid synovial fluid. Arthritis Rheum 1977; 20: 1354–8
   PubMedGoogle Scholar
• Peltonen L. Collagenase in synovial fluid. Scand J Rheumatol 1978; 7: 49–54
   PubMed Web of Science ®Google Scholar
• Wilkinson M, Jones B S. Serum and synovial fluid proteins in arthritis. Ann Rheum Dis 1962; 21: 51–8
   PubMed Web of Science ®Google Scholar
• Wiedemann D, Vitulova V. Simultaneous analysis of eighteen proteins in the sera and knee joint effusions of patients with rheumatoid arthritis and osteoarthritis. Clin Rheumatol 1986; 5: 416–9
   PubMed Web of Science ®Google Scholar
• Walters M T., Stevenson F K., Goswami R, Smith J L., Cawley M ID. Comparison of serum and synovial fluid concentrations of β2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis. Ann Rheum Dis 1989; 48: 905–11
   PubMed Web of Science ®Google Scholar